| Product Code: ETC11640225 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Serbia Chronic Obstructive Pulmonary Disorder Market Overview |
3.1 Serbia Country Macro Economic Indicators |
3.2 Serbia Chronic Obstructive Pulmonary Disorder Market Revenues & Volume, 2021 & 2031F |
3.3 Serbia Chronic Obstructive Pulmonary Disorder Market - Industry Life Cycle |
3.4 Serbia Chronic Obstructive Pulmonary Disorder Market - Porter's Five Forces |
3.5 Serbia Chronic Obstructive Pulmonary Disorder Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Serbia Chronic Obstructive Pulmonary Disorder Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Serbia Chronic Obstructive Pulmonary Disorder Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.8 Serbia Chronic Obstructive Pulmonary Disorder Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Serbia Chronic Obstructive Pulmonary Disorder Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of smoking and air pollution in Serbia, leading to a higher incidence of chronic obstructive pulmonary disorder (COPD). |
4.2.2 Growing awareness about COPD among healthcare professionals and patients, leading to early diagnosis and treatment. |
4.2.3 Advancements in medical technology and treatment options for COPD, improving patient outcomes. |
4.3 Market Restraints |
4.3.1 Limited access to healthcare services and medications for COPD patients in Serbia. |
4.3.2 Lack of public awareness and education programs about COPD prevention and management. |
4.3.3 High costs associated with COPD treatments and medications, affecting affordability for patients. |
5 Serbia Chronic Obstructive Pulmonary Disorder Market Trends |
6 Serbia Chronic Obstructive Pulmonary Disorder Market, By Types |
6.1 Serbia Chronic Obstructive Pulmonary Disorder Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Serbia Chronic Obstructive Pulmonary Disorder Market Revenues & Volume, By Drug Type, 2021 - 2031F |
6.1.3 Serbia Chronic Obstructive Pulmonary Disorder Market Revenues & Volume, By Phosphodiesterase4 Inhibitors, 2021 - 2031F |
6.1.4 Serbia Chronic Obstructive Pulmonary Disorder Market Revenues & Volume, By Bronchodilators, 2021 - 2031F |
6.1.5 Serbia Chronic Obstructive Pulmonary Disorder Market Revenues & Volume, By Corticosteroids, 2021 - 2031F |
6.1.6 Serbia Chronic Obstructive Pulmonary Disorder Market Revenues & Volume, By Combination Therapy, 2021 - 2031F |
6.2 Serbia Chronic Obstructive Pulmonary Disorder Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Serbia Chronic Obstructive Pulmonary Disorder Market Revenues & Volume, By Inhalers, 2021 - 2031F |
6.2.3 Serbia Chronic Obstructive Pulmonary Disorder Market Revenues & Volume, By Nebulizers, 2021 - 2031F |
6.3 Serbia Chronic Obstructive Pulmonary Disorder Market, By Disease Type |
6.3.1 Overview and Analysis |
6.3.2 Serbia Chronic Obstructive Pulmonary Disorder Market Revenues & Volume, By Chronic Bronchitis, 2021 - 2031F |
6.3.3 Serbia Chronic Obstructive Pulmonary Disorder Market Revenues & Volume, By Emphysema, 2021 - 2031F |
6.4 Serbia Chronic Obstructive Pulmonary Disorder Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Serbia Chronic Obstructive Pulmonary Disorder Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 Serbia Chronic Obstructive Pulmonary Disorder Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.4.4 Serbia Chronic Obstructive Pulmonary Disorder Market Revenues & Volume, By Homecare, 2021 - 2031F |
7 Serbia Chronic Obstructive Pulmonary Disorder Market Import-Export Trade Statistics |
7.1 Serbia Chronic Obstructive Pulmonary Disorder Market Export to Major Countries |
7.2 Serbia Chronic Obstructive Pulmonary Disorder Market Imports from Major Countries |
8 Serbia Chronic Obstructive Pulmonary Disorder Market Key Performance Indicators |
8.1 Average age of COPD diagnosis in Serbia. |
8.2 Percentage of COPD patients receiving guideline-recommended treatment. |
8.3 Number of COPD-related hospitalizations in Serbia. |
8.4 Average duration of COPD-related hospital stays. |
8.5 Percentage of COPD patients participating in pulmonary rehabilitation programs. |
9 Serbia Chronic Obstructive Pulmonary Disorder Market - Opportunity Assessment |
9.1 Serbia Chronic Obstructive Pulmonary Disorder Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Serbia Chronic Obstructive Pulmonary Disorder Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Serbia Chronic Obstructive Pulmonary Disorder Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.4 Serbia Chronic Obstructive Pulmonary Disorder Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Serbia Chronic Obstructive Pulmonary Disorder Market - Competitive Landscape |
10.1 Serbia Chronic Obstructive Pulmonary Disorder Market Revenue Share, By Companies, 2024 |
10.2 Serbia Chronic Obstructive Pulmonary Disorder Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here